Martin F. Bachmann

University Name

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (24)

Collaborators (13)

Pål Johansen

University of Zurich

Doris Rentsch

Professor in Molecular Plant Physiology

University of Bern

Lukas Jörg

Head, Division of Allergology and Clinical Immunology

University Hospital of Bern

Daniel E. Speiser

University of Bern

Maria Goreti Ferreira Sales

Full Professor

University of Coimbra

Cátia Moreira de Sousa

Invited Assistant Professor

University of Coimbra

Stephan von Gunten

Associate Professor

University of Bern

Ana Miguel Matos

Professor Auxiliar

Universidade de Lisboa Faculdade de Farmácia

Edward Wright

Senior Lecturer in Microbiology

University of Sussex

UNITED KINGDOM

Monique Vogel

Lisa Christ

Miriam Breunig

University of Regensburg

Burkhard Möller

University Hospital of Bern

Martin F. Bachmann

Research Interests

Explore related searches

Contact this professor

Articles (24)

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses

Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β

Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in Nicotiana benthamiana for Biotechnological Applications

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines

Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response

IgG in the control of FcεRI activation: a battle on multiple fronts.

Low Iron Diet Improves Clinical Arthritis in the Mouse Model of Collagen-Induced Arthritis

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874

CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization

IgE glycosylation is essential for the function of omalizumab

Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by ‘Vaccination’

Influence of antigen density and <scp>TLR</scp> ligands on preclinical efficacy of a <scp>VLP</scp>‐based vaccine against peanut allergy

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β

BALB/c and C3H mice are both suitable as peanut allergy models.

Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles

Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron&ndash;Carbohydrate Nanoparticles from Serum

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles

Collaborators (13)

Pål Johansen

Doris Rentsch

Lukas Jörg

Daniel E. Speiser

Maria Goreti Ferreira Sales

Cátia Moreira de Sousa

Stephan von Gunten

Ana Miguel Matos

Edward Wright

Monique Vogel

Lisa Christ

Miriam Breunig

Burkhard Möller

How do I reach out?

Meet Kite AI

Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron–Carbohydrate Nanoparticles from Serum